NEW YORK (GenomeWeb) – RainDance Technologies has filed a prospectus for an initial public offering of its stock for up to $60 million.

Billerica, Mass.-based RainDance has neither priced its shares nor said how many shares it plans to offer, but said in its Form S-1 filed with the US Securities and Exchange Commission that it plans to trade on the NASDAQ under ticker symbol "RAIN."

Merrill Lynch, Cowen and Company, and Evercore ISI Group are listed as the offering's underwriters.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.